Balance Sheets - USD ($)		Dec. 31, 2025	Dec. 31, 2024
Current assets
Cash		$ 1,126,011
Prepaid expenses and other current assets		174,127	5,532
Total Current Assets		1,300,138	5,532
Deferred offering costs			320,495
Long-term prepaid insurance		53,557
Other receivable – dividend income		824,770
Cash and marketable securities held in Trust Account		258,955,961
TOTAL ASSETS		261,134,426	326,027
Current liabilities
Accounts payable and accrued expenses		302,149	40,875
Accrued offering costs		75,000	204,608
Total current liabilities		457,974	372,367
Deferred legal fees		2,517,919	14,456
Deferred underwriting fee payable		12,045,000
TOTAL LIABILITIES		15,020,893	386,823
Commitments
Shareholders’ Deficit
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding
Additional paid-in capital			24,156
Accumulated deficit		(13,668,116)	(85,796)
Total Shareholders’ Deficit		(13,667,198)	(60,796)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT		261,134,426	326,027
Class A Ordinary Shares
Current liabilities
Class A ordinary shares subject to possible redemption, 25,300,000 and no shares at a redemption value of $10.17 and $0 per share as of September 30, 2025 and December 31, 2024, respectively		259,780,731
Shareholders’ Deficit
Ordinary shares, value	[1]	74
Class B Ordinary Shares
Shareholders’ Deficit
Ordinary shares, value	[1]	844	844
Related Party
Current liabilities
Advances from related party		80,638
Promissory note – related party		$ 187	$ 126,884

[1] On October 10, 2024, in connection with a recapitalization, the Company issued the Sponsor an additional 1,916,667 Class B ordinary shares for no additional consideration, following which the Sponsor holds 7,666,667 Class B ordinary shares. On November 18, 2024, the Company effected a share capitalization of 766,667 Class B ordinary shares, as a result of which the Sponsor owns 8,433,333 founder shares for which it paid approximately $0.003 per share. All share amounts have been retroactively restated to reflect these adjustments.